Experience with the carbamylated monomeric allergoid Lais® for sublingual immunotherapy in patients with grass pollen or mite-induced allergic rhinoconjunctivitis | Zendy

I V Danilycheva | Zendy; N I Ilina | Zendy; A E Shulzhenko | Zendy

Open Access

Experience with the carbamylated monomeric allergoid Lais® for sublingual immunotherapy in patients with grass pollen or mite-induced allergic rhinoconjunctivitis

Author(s) -

I V Danilycheva,

N I Ilina,

A E Shulzhenko

Publication year - 2015

Publication title -

russian journal of allergy

Language(s) - English

Resource type - Journals

eISSN - 2686-682X

pISSN - 1810-8830

DOI - 10.36691/rja497

Subject(s) - sublingual immunotherapy , slit , medicine , mite , desensitization (medicine) , pollen , house dust mite , sublingual administration , immunology , immunotherapy , allergy , dermatology , allergen , immune system , pharmacology , botany , receptor , biology , genetics

The article presents the results of a prospective noncomparative study of carbamylated monomeric allergoid Lais® for sublingual immunotherapy (SLIT) in patients with allergic rhinoconjunctivitis caused by pollen grasses. We suggest that SLIT using Lais® sublingual tablets is an effective and well-tolerated method of treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research